Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections.
Roth RS, Masouridi-Levrat S, Giannotti F, Mamez AC, Glambedakis E, Lamoth F, Bochud PY, Erard V, Emonet S, Van Delden C, Kaiser L, Chalandon Y, Neofytos D. Roth RS, et al. Among authors: giannotti f. Mycoses. 2022 Feb;65(2):199-210. doi: 10.1111/myc.13416. Epub 2021 Dec 29. Mycoses. 2022. PMID: 34936143 Free PMC article.
Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
Mamez AC, Pradier A, Giannotti F, Petitpas A, Urdiola MF, Vu DL, Masouridi-Levrat S, Morin S, Dantin C, Clerc-Renaud D, Eberhardt CS, Kaiser L, Simonetta F, Chalandon Y. Mamez AC, et al. Among authors: giannotti f. Bone Marrow Transplant. 2021 Dec;56(12):3094-3096. doi: 10.1038/s41409-021-01466-9. Epub 2021 Sep 28. Bone Marrow Transplant. 2021. PMID: 34584239 Free PMC article. No abstract available.
Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?
Roth RS, Masouridi-Levrat S, Chalandon Y, Mamez AC, Giannotti F, Riat A, Fischer A, Poncet A, Glampedakis E, Van Delden C, Kaiser L, Neofytos D. Roth RS, et al. Among authors: giannotti f. Open Forum Infect Dis. 2021 Nov 29;9(1):ofab596. doi: 10.1093/ofid/ofab596. eCollection 2022 Jan. Open Forum Infect Dis. 2021. PMID: 34993259 Free PMC article.
T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients.
Pradier A, Mamez AC, Stephan C, Giannotti F, Masouridi-Levrat S, Wang S, Morin S, Neofytos D, Vu DL, Melotti A, Arm I, Eberhardt CS, Tamburini J, Kaiser L, Chalandon Y, Simonetta F. Pradier A, et al. Among authors: giannotti f. Ann Oncol. 2022 Dec;33(12):1333-1335. doi: 10.1016/j.annonc.2022.09.153. Epub 2022 Sep 16. Ann Oncol. 2022. PMID: 36116692 Free PMC article. No abstract available.
Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted Grafts.
Beauverd Y, Morin S, Nabergoj M, Stephan C, De Ramon Ortiz C, Mamez AC, Mahne E, Petropoulou A, Giannotti F, Ayer C, Bruno B, Bounaix L, Anastasiou M, Mappoura M, Tran TA, Masouridi-Levrat S, Chalandon Y. Beauverd Y, et al. Among authors: giannotti f. Transplant Cell Ther. 2021 Jan;27(1):67.e1-67.e7. doi: 10.1016/j.bbmt.2020.09.022. Epub 2020 Sep 24. Transplant Cell Ther. 2021. PMID: 32980547 Free article.
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study.
Chalandon Y, Mamez AC, Giannotti F, Beauverd Y, Dantin C, Mahne E, Mappoura M, Bernard F, de Ramon Ortiz C, Stephan C, Morin S, Ansari M, Simonetta F, Masouridi-Levrat S. Chalandon Y, et al. Among authors: giannotti f. Transplant Cell Ther. 2022 Nov;28(11):765.e1-765.e9. doi: 10.1016/j.jtct.2022.08.003. Epub 2022 Aug 8. Transplant Cell Ther. 2022. PMID: 35953029 Free article.
The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft.
Beauverd Y, Morin S, Stephan C, De Ramon Ortiz C, Fabra Urdiola M, Giannotti F, Mahne E, Mamez AC, Mappoura M, Simonetta F, Tran TA, Ayer C, Noetzlin S, Verdon I, Masouridi-Levrat S, Chalandon Y. Beauverd Y, et al. Among authors: giannotti f. Bone Marrow Transplant. 2021 Sep;56(9):2284-2286. doi: 10.1038/s41409-021-01334-6. Epub 2021 May 18. Bone Marrow Transplant. 2021. PMID: 34007052 No abstract available.
98 results